All participants are invited to submit abstracts
on one of the topics listed below for
presentation at the 17^th ECCMID / 25^th ICC 2007.

Abstracts may only be submitted via internet. Late abstracts will not be considered.

In order to standardise the abstract layout, we ask you to read the preparation guidelines at
this link CAREFULLY! Avoid submission within 48 hours of the deadline for best system performance.

Guidelines for submission of abstracts:

1. Abstracts may be submitted only via internet. Abstracts submitted via fax or e-mail will not be accepted.
   
2. All abstracts must be submitted and presented in English using UK spelling.
   
3. Abstracts must contain original material neither published nor presented elsewhere
   prior to 31 March 2007.
   
4. Please structure your abstract using the following headings:
   
   • Objectives
   • Methods
   • Results
   • Conclusion
5. The abstract text may not be longer than 2'500 characters, including spaces.
   Tables, charts and other graphics are permitted and must be converted to jpg or gif format – a separate upload button is provided (max. 1 graphic of not more than 20 kb)
   
6. Avoid complex mathematical formulae.
   For the symbols ≤ or ≥ , type instead <= or >=. For superscript use caret (^) e.g. 10^6 instead of 10⁶. Do not use Greek letters and symbols. Instead of "IFN-γ" use for example "IFN-g" or "IFN-gamma".
   
7. Spelling Guidelines: The International System of Units (SI) should be used wherever appropriate. Genus and species names should be written in full on first mention and then abbreviated on subsequent mention.
   The following general rules apply (Examples in parentheses):
   
   • Systematic names (genus, family and higher orders): capitalised (Chlamydia, Enterobacteriaceae, Picornaviridae). Italicising will be done by the editors.
   • Non-systematic names (e.g. plural): lower case (Group A streptococci, mycobacteria, chlamydiae)
   • Generic drug names: lower case (penicillin)
   • Brand names: capitalised with trademark symbol (Rocephin®)
   • Diseases and viruses: lower case (hepatitis, herpes zoster, herpesvirus, West Nile virus)
   • Please observe standard English grammar rules including a space after full stops and commas.
   • For instructions on the use of abbreviations and references, please consult the ESCMID website at www.escmid.org, Clinical Mircrobiology & Infection, Guidelines for authors.
8. Authors should indicate their presentation preference:
   
   • poster only
   • oral or poster presentation
9. Authors are asked to enter 3 keywords to better define the abstract content.
   
10. After having submitted your abstract, you will receive a confirmation by e-mail with your personal address code and password. If you do not receive a confirmation by e-mail please contact the Abstract hotline (check your email address!). Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use your personal access codes.
    Corrections to abstracts can only be made up to the deadline of 16 November 2006.
    
11. Abstracts will be subject to a blind peer review by at least 3 members of the Programme Committee and external experts.
12. Authors will be notified of acceptance in the first week of January 2007 by email.
    
13. Abstract authors must register for the conference by 16 January 2007 or advise us of withdrawal. If by this date the registration fee has not been received, the abstract will not be published. Authors with accepted abstracts are entitled to the early registration fee if registered before 16 January 2007.
    
14. If an abstract is accepted, authors must attend the congress and present it in person. If a presenting author withdraws an abstract after 16 January 2007, or does not attend the session for which he or she has been scheduled, a penalty will incur prohibiting the author from presenting papers at the ECCMID meetings for a period of 3 years. Those subject to this penalty will be informed in writing.

If you have difficulties in submitting your abstracts or if you need any further information, please contact the abstract hotline:
Phone +41 61 686 77 22 (Monday – Friday during CET business hours)

Topics

Basic science
1.		Pathogenesis
2.		Animal models including experimental treatment
3.		Biofilm
Antimicrobials
4.		Antimicrobial pharmacokinetics, pharmacodynamics and general pharmacology
5.		Mechanisms of action and resistance
6.		Resistance surveillance
7.		Molecular epidemiology of resistance genes, strains and serotypes
8.		In vitro antibacterial susceptibility and drug interaction studies
9.		New antimicrobials
10.		Epidemiology of MRSA, VRE and other Gram-positives
11.		Epidemiology of MDR-Gram-negatives
12.		Antibiotic usage
Molecular biology, including diagnostics
13.		Molecular bacteriology
14.		Molecular virology
15.		Molecular typing
16.		Molecular biology, including diagnostics – others
Diagnostics
17.		Diagnostic/laboratory methods (other than molecular)
18.		Methods for antibacterial susceptibility testing
Public Health
19.		Public health and community-acquired infections
20.		Emerging infectious diseases
Infection Control
21.		Infection control
22.		Clinical epidemiology of nosocomial infections (POWI, VAP, UTI, BSI, …)
Travel medicine, tropical diseases and parasitology
23.		Travel medicine, tropical and parasitic diseases
Mycology
24.		Resistance and mechanisms of action of antifungals
25.		Fungal infections
Virology
26.		AIDS and HIV infection
27.		Hepatitis
28.		Virology non-HIV/non-hepatitis
Clinical ID
29.		Mycobacterial infections (including diagnosis)
30.		Infection in the immunocompromised host and transplant recipients
31.		Community-acquired infections including CAP, sepsis, STD, ….
32.		Lyme borreliosis, toxoplasmosis
33.		Antimicrobial clinical trials
34.		Paediatric infections
Vaccines
35.		Immunology, host defences, immunotherapy
36.		Vaccines
Internet
37.		Internet and electronic resources

Publication
All accepted abstracts will be published as an electronic supplement to Clinical Microbiology and Infection (CMI) and the International Journal of Antimicrobial Agents (IJAA), the official journals of ESCMID and ISC. All accepted abstracts will be made available to the participants on CD-Rom only. No abstract book will be printed, however a second CD containing most of the full posters will be produced. Please take advantage of the online meeting planner facility available before the congress. To this end full abstract texts will be viewable on the ECCMID/ICC website 10 days prior to the congress.

Presentation Format
Accepted abstracts are to be presented either as poster or oral presentation. Additional abstracts may be accepted for inclusion in the “publication only” section of the Abstract CD. The final decision of the presentation format will be made by the Programme Committee. Full instructions concerning the preparation and presentation will be given in the acceptance e-mail early January 2007.